Travis Sloan Chambers

Array ( [id] => 560795 [patent_doc_number] => 07157565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Far red shifted fluorescent proteins' [patent_app_type] => utility [patent_app_number] => 09/976673 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16529 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157565.pdf [firstpage_image] =>[orig_patent_app_number] => 09976673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 843811 [patent_doc_number] => 07388075 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-17 [patent_title] => 'Medicament containing activated antithrombin III' [patent_app_type] => utility [patent_app_number] => 10/380274 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 31 [patent_no_of_words] => 13041 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/388/07388075.pdf [firstpage_image] =>[orig_patent_app_number] => 10380274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6834700 [patent_doc_number] => 20030162246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Methods of synthesizing cell-free protein' [patent_app_type] => new [patent_app_number] => 10/344803 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8048 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162246.pdf [firstpage_image] =>[orig_patent_app_number] => 10344803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016049 [patent_doc_number] => 20020102709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Collagen-binding physiologically active polypeptide' [patent_app_type] => new [patent_app_number] => 09/934706 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102709.pdf [firstpage_image] =>[orig_patent_app_number] => 09934706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394271 [patent_doc_number] => 20040038370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Claudin polypeptides' [patent_app_type] => new [patent_app_number] => 10/344487 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31576 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038370.pdf [firstpage_image] =>[orig_patent_app_number] => 10344487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543002 [patent_doc_number] => 07169760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Peptides as NS3-serine protease inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 09/909012 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21124 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169760.pdf [firstpage_image] =>[orig_patent_app_number] => 09909012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329809 [patent_doc_number] => 20040254117 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel peptides as NS3-serine protease inhibitors of hepatitis C virus' [patent_app_type] => corrected [patent_app_number] => 09/908955 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39724 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0254/20040254117.pdf [firstpage_image] =>[orig_patent_app_number] => 09908955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329809 [patent_doc_number] => 20040254117 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel peptides as NS3-serine protease inhibitors of hepatitis C virus' [patent_app_type] => corrected [patent_app_number] => 09/908955 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39724 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0254/20040254117.pdf [firstpage_image] =>[orig_patent_app_number] => 09908955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 843605 [patent_doc_number] => 07387993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-17 [patent_title] => 'Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-αinhibitors' [patent_app_type] => utility [patent_app_number] => 10/332712 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7018 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/387/07387993.pdf [firstpage_image] =>[orig_patent_app_number] => 10332712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598048 [patent_doc_number] => 20020042375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Method of treating cancer' [patent_app_type] => new [patent_app_number] => 09/896245 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46064 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042375.pdf [firstpage_image] =>[orig_patent_app_number] => 09896245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797465 [patent_doc_number] => 20030176339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Novel polypeptide and its dna' [patent_app_type] => new [patent_app_number] => 10/297895 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20482 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176339.pdf [firstpage_image] =>[orig_patent_app_number] => 10297895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386362 [patent_doc_number] => 20040029780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof' [patent_app_type] => new [patent_app_number] => 10/312610 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10285 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029780.pdf [firstpage_image] =>[orig_patent_app_number] => 10312610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6129869 [patent_doc_number] => 20020076817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Labeling of proteomic samples during proteolysis for quantitation and sample multiplexing' [patent_app_type] => new [patent_app_number] => 09/878750 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16611 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076817.pdf [firstpage_image] =>[orig_patent_app_number] => 09878750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 956274 [patent_doc_number] => 06956025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-18 [patent_title] => 'Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof' [patent_app_type] => utility [patent_app_number] => 10/312517 [patent_app_country] => US [patent_app_date] => 2001-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8299 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/956/06956025.pdf [firstpage_image] =>[orig_patent_app_number] => 10312517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093482 [patent_doc_number] => 06825329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Human PEM as a target for birth control and treatment of Alzheimer\'s disease' [patent_app_type] => B2 [patent_app_number] => 09/867753 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4552 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825329.pdf [firstpage_image] =>[orig_patent_app_number] => 09867753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730654 [patent_doc_number] => 20030186844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Gherlin analogs' [patent_app_type] => new [patent_app_number] => 10/276392 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7692 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186844.pdf [firstpage_image] =>[orig_patent_app_number] => 10276392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711811 [patent_doc_number] => 20030171560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Purification of protein inclusion bodies by crossflow microfiltration' [patent_app_type] => new [patent_app_number] => 10/275797 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9998 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171560.pdf [firstpage_image] =>[orig_patent_app_number] => 10275797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056267 [patent_doc_number] => 06855490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Method for attaching biological molecules to a glass surface' [patent_app_type] => utility [patent_app_number] => 09/834240 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 15486 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855490.pdf [firstpage_image] =>[orig_patent_app_number] => 09834240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1124311 [patent_doc_number] => 06794493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-21 [patent_title] => 'Antithrombin H-helix mutants' [patent_app_type] => B2 [patent_app_number] => 09/828592 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 11740 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794493.pdf [firstpage_image] =>[orig_patent_app_number] => 09828592 [rel_patent_id] =>[rel_patent_doc_number] =>)